Skip to main content
. 2006 Oct 30;63(4):438–450. doi: 10.1111/j.1365-2125.2006.02778.x

Figure 5.

Figure 5

(a) The percentage of patients achieving the therapeutic target range (Cmin,ss = 0.5–2 mg l−1) with different dosing schedules. (b) The percentage of patients at risk of toxicity at these doses. bd, Twice daily; d, once daily; white bars, solution; grey bars, capsules